Concerns arose months ago that the insurer was not approving or paying for the nuclear cardiac stress tests, which were requested by Delaware physicians to diagnoses heart blockages.
According to the report, Ms. Stewart has also said BCBS of Delaware will enter a new pilot program with the American College of Cardiology, which ensures the tests of patients enrolled in the program will be automatically approved. If BCBS of Delaware does not go through with the program, it could face an additional $300,000 charge to “address the concerns uncovered in the examination,” the report said.
Related Articles on Blue Cross Blue Shield:
BCBS Provides $275K to Train Family Physicians in Tennessee
Judge Denies BCBS of Michigan’s Appeal to Dismiss Antitrust Suit
BCBS of Michigan’s Move Into Medicaid Attracts Criticism
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
